Sign Up to like & get
recommendations!
0
Published in 2021 at "Drug discovery today"
DOI: 10.1016/j.drudis.2021.03.005
Abstract: The utilization of either aqueous or conventional/traditional volatile organic compound-based extraction/product development processes in the pharmaceutical industry has become questionable because of the water solubility limitations of active pharmaceutical ingredients (APIs) and stringent regulatory issues…
read more here.
Keywords:
product development;
neoteric solvents;
pharmaceutical industry;
solvents pharmaceutical ... See more keywords